Weekly Funding Opportunity Announcement ARCHIVE of ALL CURRENT OPPORTUNITIES July 26, 2021

Weekly Funding Opportunity Announcement ARCHIVE of ALL CURRENT OPPORTUNITIES July 26, 2021

Weekly Funding Opportunity Announcement ARCHIVE OF ALL CURRENT OPPORTUNITIES July 26, 2021 COVID-19 Funding ORSD posts a COVID-19 newsletter highlighting research funding opportunities along with answers to questions regarding how COVID-19-related disruptions to research might affect current federal funding. NIH Funding Announcements ACTIVE LIMITED SUBMISSION OPPORTUNITIES: **NEW – Limited Submission: NIH: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Internal deadline: July 30, 2021 Sponsor deadline: Rolling If you are interested in applying for this award, you must submit a brief Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited submission – NIH: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32) Internal deadline: July 30, 2021 Sponsor deadline: September 27, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited Submission – NIH: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C) Internal deadline: July 30, 2021 Sponsor deadline: October 14, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited Submission – NIH: Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25) Internal deadline: July 30, 2021 Sponsor deadline: September 27, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited Submission – NIH: Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Internal deadline: July 30, 2021 Sponsor deadline: September 27, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited Submission – NIH: NEI Center Core Grant for Vision Research (P30) Internal deadline: July 30, 2021 Sponsor deadline: September 30, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. **NEW: Limited Submission – NIH: Institutional Development Award (IDeA) Networks for Clinical and Translational Research (IDeA-CTR) (U54) Internal deadline: July 30, 2021 Sponsor deadline: October 7, 2021 Please note: This LSO has multiple deadlines. If you plan on applying for the upcoming deadline, please submit a Notice of Intent including PI name, department, and a brief (1-2 sentence) description of the proposed project to the Office of Research Strategy and Development ([email protected]) no later than July 30, 2021. Based on the number of notices received, we will determine whether an internal competition is needed. NEW RFAs: *NEW: NIH: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed) Deadline: 10/29/2021 *NEW: NIH: Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Deadline: 02/18/2022 *NEW: NIH: Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) Deadline: 10/21/2021 *NEW: NIH: Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) Deadline: 10/08/2021 *NEW: NIH: Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed) Deadline: 10/08/2021 *NEW: NIH: Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) Deadline: 10/21/2021 *NEW: NIH: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) Deadline: 10/12/2021 *NEW: NIH: Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) Deadline: 03/04/2022 *NEW: NIH: Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) Deadline: 03/04/2022 *NEW: NIH: Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) Deadline: 10/21/2021 *NEW: NIH: Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) Deadline: 11/03/2021 *NEW: NIH: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) Deadline: 10/09/2021 *NEW: NIH: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) Deadline: 10/22/2021 *NEW: NIH: Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Deadline: 11/01/2021 *NEW: NIH: Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) Deadline: 10/01/2021 *NEW: NIH: Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) Deadline: 08/11/2022 *NEW: NIH: Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) Deadline: 12/06/2021 NEW PAs: *NEW: NIH: Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) Deadline: 10/06/2021 *NEW: NIH: Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) Deadline: 10/05/2021 *NEW: NIH: Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) Deadline: 03/05/2022 *NEW: NIH: Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) Deadline: 03/05/2022 *NEW: NIH: NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Deadline: 10/12/2021 *NEW: NIH: PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Deadline: 09/06/2021 *NEW: NIH: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) Deadline: 09/06/2021 *NEW: NIH: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Deadline: 09/06/2021 *NEW: NIH: PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Deadline: 09/06/2021 *NEW: NIH: Large Research Projects for Prevention of Healthcare-Associated Infections (R01) Deadline: 08/06/2021 *NEW: NIH: Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Deadline: 11/01/2021 *NEW: NIH: Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Deadline: 11/01/2021 *NEW: NIH: NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Deadline: 09/08/2021 *NEW: NIH: NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) Deadline: 09/06/2021 *NEW: NIH: NINDS Renewal

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    33 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us